Medtronic vs Sanofi
Medtronic (MDT), health care, and Sanofi (SNY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Medtronic is worth $132.1B on the stock market and Sanofi $115B: Medtronic is valued at 15% more. Medtronic trades at 25.4 times earnings and Sanofi at 23.8; operating margins in their latest fiscal years were 17.8% and 14.5%. Over the past year Medtronic's share price has moved +2.06% and Sanofi's -4.48%.
Key facts
- Medtronic market value
- $132.1B
- Sanofi market value
- $115B
- Medtronic P/E
- 25.4
- Sanofi P/E
- 23.8
- Medtronic revenue
- $36.4BFY to 2026-04-24
- Sanofi revenue
- $48.4BFY to 2025-12-31
- Superinvestors holding both
- 2
Market values as of .
| Measure | Medtronic | Sanofi |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-04-24 | 2025-12-31 |
| Size | ||
| Market cap | $132.1Bhigher | $115Blower |
| Revenue | $36.4Blower | $48.4Bhigher |
| Earnings | $4.8Blower | $8.7Bhigher |
| Employees | 95,000higher | 74,846lower |
| Total assets | $93Blower | $140.7Bhigher |
| Valuation | ||
| P/E | 25.4higher | 23.8lower |
| P/S | 3.6higher | 2.4lower |
| P/B | — | — |
| Dividend yield | — | — |
| Profitability | ||
| Operating margin | 17.8%higher | 14.5%lower |
| Balance sheet | ||
| Net assets | $49.5Blower | $79.2Bhigher |
| Total liabilities | $43Blower | $61.1Bhigher |
| Total debt | $28Bhigher | $20.8Blower |
| Cash on hand | $1.9Blower | $8.5Bhigher |
| Price change | ||
| Today | +0.38%higher | -1.05%lower |
| 1 year | +2.06%higher | -4.48%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (2)
- Richard Pzena0.8% / <0.1%
- Dodge & Cox team0.3% / 0.3%
Medtronic only (8)
- Matthew McLennan1.9%
- Diamond Hill team1.4%
- Howard Gleicher1.2%
- Mark Boyar0.4%
- Mairs & Power team0.3%
- Ken Griffin0.2%
- David Shaw (founder)0.2%
- Ray Dalio (founder)0.2%
Sanofi only (5)
- Charles Brandes (founder)1.2%
- Louis Bacon0.5%
- Sarah Ketterer0.4%
- Ken Fisher0.1%
- Lee Ainslie<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Medtronic / Sanofi). Who owns MDT · Who owns SNY
More on Medtronic
Further comparisons
Medtronic against its closest peers
Sanofi against its closest peers
Learn
Questions and answers
Which is bigger, Medtronic or Sanofi?
By market value, Medtronic is the larger: $132.1B against $115B for Sanofi. By revenue in its latest fiscal year, Sanofi is the larger: $48.4B against $36.4B for Medtronic.
Which has the higher P/E ratio?
Medtronic: 25.4, against 23.8 for Sanofi. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Medtronic: 17.8%, against 14.5% for Sanofi. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Medtronic: $28B, against $20.8B for Sanofi. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Medtronic and Sanofi?
In their latest 13F filings, Richard Pzena and Dodge & Cox team hold both.
Cite this page
Funkfolio, “Medtronic vs Sanofi”, data as of 17 November 2026. https://funkfolio.com/compare/mdt-vs-sny
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.